Indian billionaires buy foreign companies as growth slows at home
Indian billionaires are increasingly acquiring foreign companies as domestic growth slows. Recent high-profile deals include Sun Pharmaceuticals' $11.75 billion purchase of Organon & Co and Tata Motors' $4.4 billion acquisition of Iveco. Analysts suggest that these acquisitions are driven by strategic needs rather than mere ambition, reflecting a shift in the economic landscape.
- ▪Sun Pharmaceuticals agreed to acquire Organon & Co for $11.75 billion, marking the largest overseas acquisition by an Indian company in nearly two decades.
- ▪162 Indian companies spent over $18 billion on outbound acquisitions in 2025, a 34% increase from the previous year.
- ▪Experts indicate that Indian firms are seeking Western assets for better diversification and operational capabilities.
BBC News — Business publishes from United Kingdom and files mainly under business. We currently carry 134 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | BBC News — Business |
| Canonical URL | https://www.bbc.com/news/articles/cwy21x20q23o?at_medium=RSS&at_campaign=rss |
| Publication time | Sun, 24 May 2026 23:01:09 GMT |
| Retrieval time | 2026-05-24T23:42:34.910Z |
| Last seen | 2026-05-24T23:42:34.910Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | q0YxD39AxsxH |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Indian billionaires buy foreign companies as growth slows at home40 minutes agoShareSaveAdd as preferred on GoogleNikhil InamdarMumbaiBloomberg via Getty ImagesIndia's Sun Pharmaceuticals paid $11.75bn to buy New York-listed Organon & CoIn late April, India's Sun Pharmaceuticals agreed to pay $11.75bn (£8.59bn) to acquire New York-listed women's health and biosimilars firm Organon & Co.It marked the biggest overseas acquisition by an Indian company in nearly two decades and followed a string of high-profile international deals by Indian firms in recent months.These include Tata Motors' $4.4bn acquisition of Turin-based vehicle maker Iveco, IT company Coforge's $2.35bn purchase of Silicon Valley-based AI firm Encora and the Bajaj Group buying a 23% stake in global insurance giant Allianz…
Excerpt limited to ~120 words for fair-use compliance. The full article is at BBC News — Business.
Discussion
0 commentsMore from BBC News — Business
